Aurinia Pharmaceuticals Inc
General ticker "AUPH" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.3B
Aurinia Pharmaceuticals Inc follows the US Stock Market performance with the rate: 25.4%.
Estimated limits based on current volatility of 1.6%: low 8.80$, high 9.08$
Factors to consider:
- US accounted for 90.0% of revenue in the fiscal year ended 2023-12-31
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [6.24$, 13.32$]
- 2024-12-30 to 2025-12-30 estimated range: [7.73$, 15.66$]
Financial Metrics affecting the AUPH estimates:
- Negative: Non-GAAP EPS, $ of -0.54 <= 0.10
- Negative: Operating profit margin, % of -35.43 <= 1.03
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Operating cash flow per share per price, % of -2.55 <= 2.35
- Positive: Interest expense per share, $ of 0.02 <= 0.14
- Negative: negative Net income
Short-term AUPH quotes
Long-term AUPH plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $45.03MM | $135.55MM | $167.13MM |
| Operating Expenses | $225.77MM | $247.02MM | $258.82MM |
| Operating Income | $-180.74MM | $-111.47MM | $-91.69MM |
| Non-Operating Income | $0.53MM | $5.12MM | $14.22MM |
| Interest Expense | $0.00MM | $0.00MM | $2.77MM |
| R&D Expense | $51.14MM | $44.99MM | $49.64MM |
| Income(Loss) | $-180.21MM | $-106.35MM | $-77.47MM |
| Taxes | $0.76MM | $1.83MM | $0.55MM |
| Profit(Loss) | $-180.97MM | $-108.18MM | $-78.02MM |
| Stockholders Equity | $479.09MM | $405.44MM | $377.95MM |
| Inventory | $19.33MM | $24.75MM | $39.70MM |
| Assets | $543.37MM | $470.86MM | $548.06MM |
| Operating Cash Flow | $-157.69MM | $-79.53MM | $-33.46MM |
| Capital expenditure | $1.50MM | $0.29MM | $0.72MM |
| Investing Cash Flow | $-103.87MM | $-60.63MM | $-6.71MM |
| Financing Cash Flow | $221.11MM | $2.43MM | $-5.13MM |
| Earnings Per Share* | $-1.40 | $-0.76 | $-0.54 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.